11-108317499-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000051.4(ATM):c.6325T>G(p.Trp2109Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W2109C) has been classified as Uncertain significance.
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.6325T>G | p.Trp2109Gly | missense_variant | 43/63 | ENST00000675843.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATM | ENST00000675843.1 | c.6325T>G | p.Trp2109Gly | missense_variant | 43/63 | NM_000051.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 28
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 28
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The p.W2109G variant (also known as c.6325T>G), located in coding exon 42 of the ATM gene, results from a T to G substitution at nucleotide position 6325. The tryptophan at codon 2109 is replaced by glycine, an amino acid with highly dissimilar properties. This alteration was reported in the homozygous state in two related individuals with mild, atypical ataxia-telangiectasia (AT). Cellular lysates from patients demonstrated absence of ATM protein expression and autophosphorylation after radiation (Silvestri G et al. J. Neurol., 2010 Oct;257:1738-40). This alteration was also detected together with another ATM missense alteration in an unrelated individual with aytpical AT. In vitro analysis showed normal ATM protein expression level, autophosphorylation and radiosensitivity (Mitui M et al. Hum. Mutat., 2009 Jan;30:12-21). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Apr 12, 2022 | This missense variant replaces tryptophan with glycine at codon 2109 of the ATM protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Functional studies have conflicting reports of variant impact on protein kinase activity (PMID: 18634022, 20480175). This variant has been reported in individuals with atypical, mild, late-onset A-T in biallelic individuals (PMID 20480175, 18634022). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 11, 2024 | Observed in the compound heterozygous and homozygous state in patients with atypical ataxia telangiectasia referred for genetic testing at GeneDx and in published literature (PMID: 18634022, 20480175); Published functional studies are conflicting with respect to effect on ATM protein levels and kinase activity (PMID: 18634022, 20480175); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18634022, 30504431, 25122203, 23632773, 23509889, 27181190, 20480175, 23532176) - |
Familial cancer of breast Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 23, 2023 | - - |
Ataxia-telangiectasia syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change does not substantially affect ATM function (PMID: 18634022). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 407649). This missense change has been observed in individuals with ataxia-telangiectasia (PMID: 18634022, 20480175). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tryptophan, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 2109 of the ATM protein (p.Trp2109Gly). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at